HomeNewsNHIA Expands Cancer Coverage, Cuts Drug Costs by 80% for Eligible Patients

NHIA Expands Cancer Coverage, Cuts Drug Costs by 80% for Eligible Patients

Fidelia Soriwei, Abuja

The National Health Insurance Authority has expanded health insurance coverage for cancer treatment, introducing measures aimed at reducing the financial burden faced by patients and their families across Nigeria.

The initiative includes a cost-sharing arrangement that protects eligible beneficiaries from up to 80 per cent of the cost of selected cancer medicines, while also providing additional support for radiotherapy, diagnostic tests and other critical cancer care services.

In a statement issued on Sunday to mark Breast Cancer Awareness Month, the NHIA said the reforms were designed to ensure that health insurance delivers meaningful financial protection against costly illnesses.

“The critical measure of the insurance system should no longer be the number of Nigerians carrying insurance records, but whether those records provide meaningful protection when illness strikes,” NHIA Director-General, Dr Kelechi Ohiri, said.

Under an expanded partnership between the NHIA and pharmaceutical company Roche, the company will cover 50 per cent of the cost of selected oncology medicines, while the NHIA will pay 30 per cent, leaving eligible patients to contribute only 20 per cent.

“Under the cost-sharing arrangement, Roche bears 50 per cent of the cost of selected medicines, the NHIA contributes 30 per cent, while the patient pays 20 per cent. The initiative shields eligible patients from 80 per cent of the cost of the affected medicines.

“NHIA has also introduced additional support ranging from up to N400,000 to full coverage for eligible radiotherapy patients, complementing existing benefits for cancer care. These include mammography, CT and MRI scans, bone scans, cancer-related laboratory and diagnostic tests and radiotherapy,” the statement read.

The authority noted that cancer treatment often places severe financial pressure on households because patients frequently require surgery, chemotherapy, radiotherapy, specialised medicines and repeated diagnostic investigations.

According to the NHIA, existing benefit packages also provide support for cancer screening, surgery, chemotherapy and follow-up care, depending on the programme available to beneficiaries.

Highlighting the scale of the challenge, the authority cited data from the Global Cancer Observatory showing that Nigeria records about 32,278 new breast cancer cases and 16,332 breast cancer deaths annually.

The NHIA said breast cancer remains the most commonly diagnosed cancer among Nigerian women and one of the leading causes of cancer-related deaths in the country.

It added that the Federal Government disclosed in July 2026 that Nigeria accounts for about 10.5 per cent of Africa’s total cancer burden, placing the country among the three most affected nations on the continent.

The authority said more than 23 million Nigerians are currently enrolled in the national health insurance system, providing a platform for expanding support for cancer treatment and other high-cost diseases.

The NHIA noted that its interventions complement ongoing Federal Government efforts under the National Cancer Control Plan 2026-2030, including the upgrade of six Oncology Centres of Excellence and programmes that provide anti-cancer medicines and treatment support for indigent patients.

While acknowledging that more work remains, the authority urged women to embrace breast cancer screening and seek medical attention promptly when they notice unusual changes, stressing that early diagnosis and wider access to treatment remain critical to reducing cancer-related deaths and financial hardship.

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Recent Comments